↓ Skip to main content

St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial

Overview of attention for article published in Psychopharmacology, July 2002
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy
2 policy sources
video
1 YouTube creator

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
70 Mendeley
Title
St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial
Published in
Psychopharmacology, July 2002
DOI 10.1007/s00213-002-1171-6
Pubmed ID
Authors

Hans-Peter Volz, Harald Murck, Siegfried Kasper, Hans-Jürgen Möller

Abstract

Preliminary data have shown that St John's wort might possess some specific efficacy in patients with somatoform complaints. Therefore, the efficacy of the Hypericum extract LI 160 in patients with somatoform disorders should be studied in a double-blind placebo-controlled fashion.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
Norway 1 1%
Unknown 68 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 17%
Student > Master 9 13%
Student > Ph. D. Student 6 9%
Researcher 5 7%
Student > Doctoral Student 4 6%
Other 15 21%
Unknown 19 27%
Readers by discipline Count As %
Medicine and Dentistry 16 23%
Psychology 16 23%
Unspecified 4 6%
Nursing and Health Professions 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 7 10%
Unknown 20 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2023.
All research outputs
#5,339,559
of 25,374,917 outputs
Outputs from Psychopharmacology
#1,298
of 5,320 outputs
Outputs of similar age
#6,443
of 37,264 outputs
Outputs of similar age from Psychopharmacology
#10
of 32 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,320 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 37,264 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.